UBS AM
OPTN

UBS AM’s OptiNose OPTN Stock Holding History

UBS AM’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,103
Closed -$74.3K – 2516
2020
Q1 		$74.3K Sell
1,103
-622
-36% -$62.6K ﹤0.01% 2416
2019
Q4 		$239K Sell
1,725
-13
-0.7% -$1.69K ﹤0.01% 2428
2019
Q3 		$183K Buy
1,738
+1,058
+156% +$106K ﹤0.01% 2600
2019
Q2 		$72.3K Buy
+680
New +$89.6K ﹤0.01% 2669

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

UBS AM's OPTN Position: Q2 2020 in Review

UBS AM sold out of OptiNose (OPTN) in Q2 2020, closing a stake of 1,103 shares — an estimated $74.3K sold.

UBS AM first reported a position in OPTN in Q2 2019 and held it in 4 quarters. The position peaked at $239K in Q4 2019. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2020.

  • UBS AM reported no remaining OptiNose position as of Q2 2020 after selling out during the quarter.
  • UBS AM sold 1,103 OptiNose shares in Q2 2020, an estimated $74.3K.
  • UBS AM first reported a position in OptiNose in Q2 2019 and held it in 4 quarters.
  • UBS AM's OptiNose position peaked at $239K in Q4 2019.
  • 72 funds tracked by Wall St. Rank held OptiNose as of Q2 2020.

Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.